Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Patient-Controlled Analgesic Pumps Market, by Type
1.4.2 Europe Patient-Controlled Analgesic Pumps Market, by Application
1.4.3 Europe Patient-Controlled Analgesic Pumps Market, by End Use
1.4.4 Europe Patient-Controlled Analgesic Pumps Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements,
3.2.2 Geographical Expansions
3.2.3 Approvals & Trials
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Europe Patient-Controlled Analgesic Pumps Market by Type
4.1 Europe Electronic Market by Country
4.2 Europe Others Market by Country
Chapter 5. Europe Patient-Controlled Analgesic Pumps Market by Application
5.1 Europe Oncology Market by Country
5.2 Europe Diabetes Market by Country
5.3 Europe Hematology Market by Country
5.4 Europe Gastroenterology Market by Country
5.5 Europe Other Application Market by Country
Chapter 6. Europe Patient-Controlled Analgesic Pumps Market by End-use
6.1 Europe Hospitals Market by Country
6.2 Europe Specialty Clinics Market by Country
6.3 Europe Ambulatory Surgical Centers Market by Country
6.4 Europe Home Care Settings Market by Country
Chapter 7. Europe Patient-Controlled Analgesic Pumps Market by Country
7.1 Germany Patient-Controlled Analgesic Pumps Market
7.1.1 Germany Patient-Controlled Analgesic Pumps Market by Type
7.1.2 Germany Patient-Controlled Analgesic Pumps Market by Application
7.1.3 Germany Patient-Controlled Analgesic Pumps Market by End-use
7.2 UK Patient-Controlled Analgesic Pumps Market
7.2.1 UK Patient-Controlled Analgesic Pumps Market by Type
7.2.2 UK Patient-Controlled Analgesic Pumps Market by Application
7.2.3 UK Patient-Controlled Analgesic Pumps Market by End-use
7.2.3.1 France Patient-Controlled Analgesic Pumps Market
7.2.3.1.1 France Patient-Controlled Analgesic Pumps Market by Type
7.2.3.1.2 France Patient-Controlled Analgesic Pumps Market by Application
7.2.3.1.3 France Patient-Controlled Analgesic Pumps Market by End-use
7.2.3.2 Russia Patient-Controlled Analgesic Pumps Market
7.2.3.2.1 Russia Patient-Controlled Analgesic Pumps Market by Type
7.2.3.2.2 Russia Patient-Controlled Analgesic Pumps Market by Application
7.2.3.2.3 Russia Patient-Controlled Analgesic Pumps Market by End-use
7.2.3.3 Spain Patient-Controlled Analgesic Pumps Market
7.2.3.3.1 Spain Patient-Controlled Analgesic Pumps Market by Type
7.2.3.3.2 Spain Patient-Controlled Analgesic Pumps Market by Application
7.2.3.3.3 Spain Patient-Controlled Analgesic Pumps Market by End-use
7.2.3.4 Italy Patient-Controlled Analgesic Pumps Market
7.2.3.4.1 Italy Patient-Controlled Analgesic Pumps Market by Type
7.2.3.4.2 Italy Patient-Controlled Analgesic Pumps Market by Application
7.2.3.4.3 Italy Patient-Controlled Analgesic Pumps Market by End-use
7.2.3.5 Rest of Europe Patient-Controlled Analgesic Pumps Market
7.2.3.5.1 Rest of Europe Patient-Controlled Analgesic Pumps Market by Type
7.2.3.5.2 Rest of Europe Patient-Controlled Analgesic Pumps Market by Application
7.2.3.5.3 Rest of Europe Patient-Controlled Analgesic Pumps Market by End-use
Chapter 8. Company Profiles
8.1 Smiths Group PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Approvals & Trials:
8.2 Fresenius SE & Co. KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Baxter International, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.1 Recent strategies and developments:
8.4.1.1 Approvals & Trials:
8.4.1.2 Acquisition and Mergers:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals & Trials:
8.5.5.2 Acquisition and Mergers:
8.6 Terumo Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals & Trials:
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Avante Health Solutions
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 ICU Medical, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.9.2.3 Geographical Expansions:
8.10. Ace Medical Co., Ltd.
8.10.1 Company Overview
Unique Offerings 